gmp rv16 hrv-16
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02910401)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human rhinovirus 16Immunity, active
Human rhinovirus 16 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gmp rv16 hrv-16
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02910401 | Phase 2 | Sep 1, 2016 | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), University of Virginia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2016 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2016 |
| University of Virginia | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1